Amido poroso como dispositivo de amorfização de carvedilol
Main Author: | |
---|---|
Publication Date: | 2022 |
Format: | Bachelor thesis |
Language: | por |
Source: | Biblioteca Digital de Monografias da UFMT |
Download full: | http://bdm.ufmt.br/handle/1/2484 |
Summary: | Carvedilol is a Class II drug, according to the Biopharmaceutical Classification System (BCS), with low solubility and high permeability. One way to circumvent this condition is to obtain an amorphous material, the problem for such material is its instability. In this sense, amorphization of Active Pharmaceutical Ingredients (APIs) in porous adsorbent systems is very promising, since molecular interactions between the new solid form of the drug and the adsorbent systems can prevent its recrystallization. Therefore, we sought to develop a system for amorphizing Carvedilol based on porous starch matrices. The starch hydrogel was produced by incorporating water under heating and constant stirring, then the water was gradually replaced by ethanol from the system and finally the ethanol was removed by rotary evaporation. In this way, the pores of the starch were formed. The incorporation of the API was carried out by the method of loading by solvent evaporation and physical mixing, in proportions of 1:1, 2:1 and 3:1. The samples were submitted to Fourier transform infrared (FTIR), thermogravimetric (TGA), differential scanning calorimetry (DSC) and X-ray diffraction analysis. In the Thermogravimetric results for the system with solvent incorporation, there was a significant change in the behavior of the thermal transition referring to melting, so that, in the 3:1 ratio, the melting peak disappears. Infrared spectra corroborate the presence of the drug within the polymer matrix. Such statement can be confirmed by the characteristic band of the carvedilol drug at 1592 cm-1. XRD revealed that for the macerated system there was no adequate incorporation of the API to the matrix, but for the system with solvent incorporation, the Bragg peaks of the drug disappeared as the proportion of the porous matrix increased. Thus, it is possible to affirm that ASP is an excellent strategy for the amorphization of Carvedilol. |
id |
UFMT-1_d8ae4bce13d1d5f35be0ee7eaacdf725 |
---|---|
oai_identifier_str |
oai:localhost:1/2484 |
network_acronym_str |
UFMT-1 |
network_name_str |
Biblioteca Digital de Monografias da UFMT |
repository_id_str |
|
spelling |
Amido poroso como dispositivo de amorfização de carvedilolCNPQ::CIENCIAS DA SAUDE::FARMACIACarvedilolASPAmorfizaçãoCarvedilolASPAmorphizationCarvedilol is a Class II drug, according to the Biopharmaceutical Classification System (BCS), with low solubility and high permeability. One way to circumvent this condition is to obtain an amorphous material, the problem for such material is its instability. In this sense, amorphization of Active Pharmaceutical Ingredients (APIs) in porous adsorbent systems is very promising, since molecular interactions between the new solid form of the drug and the adsorbent systems can prevent its recrystallization. Therefore, we sought to develop a system for amorphizing Carvedilol based on porous starch matrices. The starch hydrogel was produced by incorporating water under heating and constant stirring, then the water was gradually replaced by ethanol from the system and finally the ethanol was removed by rotary evaporation. In this way, the pores of the starch were formed. The incorporation of the API was carried out by the method of loading by solvent evaporation and physical mixing, in proportions of 1:1, 2:1 and 3:1. The samples were submitted to Fourier transform infrared (FTIR), thermogravimetric (TGA), differential scanning calorimetry (DSC) and X-ray diffraction analysis. In the Thermogravimetric results for the system with solvent incorporation, there was a significant change in the behavior of the thermal transition referring to melting, so that, in the 3:1 ratio, the melting peak disappears. Infrared spectra corroborate the presence of the drug within the polymer matrix. Such statement can be confirmed by the characteristic band of the carvedilol drug at 1592 cm-1. XRD revealed that for the macerated system there was no adequate incorporation of the API to the matrix, but for the system with solvent incorporation, the Bragg peaks of the drug disappeared as the proportion of the porous matrix increased. Thus, it is possible to affirm that ASP is an excellent strategy for the amorphization of Carvedilol.O carvedilol é um fármaco da Classe II, de acordo com o Sistema de Classificação Biofarmacêutica (BCS), apresentando baixa solubilidade e alta permeabilidade. Uma forma de contornar essa condição é a obtenção de um material amorfo, o problema para tal material é a sua instabilidade. Nesse sentido, amorfização dos Insumos farmacêuticos ativos (IFAs) em sistemas adsorventes porosos mostra-se bastante promissora, uma vez que interações moleculares entre a nova forma sólida do fármaco com os sistemas adsorventes podem evitar a sua recristalização. Sendo assim, buscou-se desenvolver um sistema para amorfização de Carvedilol baseado em matrizes porosas de amido. O hidrogel de amido foi produzido mediante a incorporação de água sob aquecimento e agitação constante, posteriormente a água foi substituída do sistema por etanol gradualmente e por fim o etanol retirado por rotaevaporação. Dessa forma, formou-se os poros do amido. A incorporação da IFA se deu pelo método de carregamento pela evaporação do solvente e mistura física, isso nas proporções de 1:1, 2:1 e 3:1. As amostras foram submetidas a análise de infravermelho por transformada de Fourier (FTIR), termogravimétrica (TGA), calorimetria exploratória diferencial (DSC) e difração de raios-X. Nos resultados Termogravimétrico para o sistema com incorporação por solvente houve significativa mudança no comportamento dos transição térmica referente a fusão, de modo que, na proporção 3:1 o pico de fusão desaparece. Os espectros infravermelhos corroboram a presença do fármaco dentro da matriz polimérica. Tal afirmação pode-se confirmar pela banda característica do frmaco carvedilol em 1592 cm-1 . O DRX revelou que os para o sistema macerado não houve adequada incorporação do IFA à matriz, mas para o sistema com incorporação por solvente os picos de Bragg do fármaco foram desaparecem a medida que há aumento da proporção da matriz porosa. Dessa forma, é possível afirmar que o ASP configura-se como uma excelente estratégia para a amorfização do Carvedilol.Universidade Federal de Mato GrossoBrasilInstituto de Ciências Biológicas e da Saúde (ICBS) – AraguaiaUFMT CUA - AraguaiaFarmácia - CUAResende, Jackson Antônio Lamounier Camargos2938388317505882http://lattes.cnpq.br/2938388317505882Resende, Jackson Antonio Lamounier Camargos2938388317505882http://lattes.cnpq.br/2938388317505882Carneiro, Wilsione José5779208233851255http://lattes.cnpq.br/5779208233851255Véliz, Arturo Bismarck Linares0829821672032055http://lattes.cnpq.br/0829821672032055Oliveira, Israel de França de2022-09-16T15:10:33Z2022-07-212022-09-16T15:10:33Z2022-07-07info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/bachelorThesisinfo:eu-repo/semantics/datasetOLIVEIRA, Israel de França de. Amido poroso como dispositivo de amorfização de carvedilol. 2022. 44 f. Monografia (Bacharelado em Farmácia) - Instituto de Ciências Biológicas e da Saúde, Universidade Federal de Mato Grosso, Barra do Garças, 2022.http://bdm.ufmt.br/handle/1/2484porinfo:eu-repo/semantics/openAccessreponame:Biblioteca Digital de Monografias da UFMTinstname:Universidade Federal de Mato Grosso (UFMT)instacron:UFMT2022-09-18T07:03:22Zoai:localhost:1/2484Biblioteca Digital de Monografiahttps://bdm.ufmt.br/PUBhttp://200.129.241.122/oai/requestopendoar:2022-09-18T07:03:22falseBiblioteca Digital de Monografiahttps://bdm.ufmt.br/PUBhttp://200.129.241.122/oai/requestbibliotecacentral@ufmt.br||opendoar:2022-09-18T07:03:22Biblioteca Digital de Monografias da UFMT - Universidade Federal de Mato Grosso (UFMT)false |
dc.title.none.fl_str_mv |
Amido poroso como dispositivo de amorfização de carvedilol |
title |
Amido poroso como dispositivo de amorfização de carvedilol |
spellingShingle |
Amido poroso como dispositivo de amorfização de carvedilol Oliveira, Israel de França de CNPQ::CIENCIAS DA SAUDE::FARMACIA Carvedilol ASP Amorfização Carvedilol ASP Amorphization |
title_short |
Amido poroso como dispositivo de amorfização de carvedilol |
title_full |
Amido poroso como dispositivo de amorfização de carvedilol |
title_fullStr |
Amido poroso como dispositivo de amorfização de carvedilol |
title_full_unstemmed |
Amido poroso como dispositivo de amorfização de carvedilol |
title_sort |
Amido poroso como dispositivo de amorfização de carvedilol |
author |
Oliveira, Israel de França de |
author_facet |
Oliveira, Israel de França de |
author_role |
author |
dc.contributor.none.fl_str_mv |
Resende, Jackson Antônio Lamounier Camargos 2938388317505882 http://lattes.cnpq.br/2938388317505882 Resende, Jackson Antonio Lamounier Camargos 2938388317505882 http://lattes.cnpq.br/2938388317505882 Carneiro, Wilsione José 5779208233851255 http://lattes.cnpq.br/5779208233851255 Véliz, Arturo Bismarck Linares 0829821672032055 http://lattes.cnpq.br/0829821672032055 |
dc.contributor.author.fl_str_mv |
Oliveira, Israel de França de |
dc.subject.por.fl_str_mv |
CNPQ::CIENCIAS DA SAUDE::FARMACIA Carvedilol ASP Amorfização Carvedilol ASP Amorphization |
topic |
CNPQ::CIENCIAS DA SAUDE::FARMACIA Carvedilol ASP Amorfização Carvedilol ASP Amorphization |
description |
Carvedilol is a Class II drug, according to the Biopharmaceutical Classification System (BCS), with low solubility and high permeability. One way to circumvent this condition is to obtain an amorphous material, the problem for such material is its instability. In this sense, amorphization of Active Pharmaceutical Ingredients (APIs) in porous adsorbent systems is very promising, since molecular interactions between the new solid form of the drug and the adsorbent systems can prevent its recrystallization. Therefore, we sought to develop a system for amorphizing Carvedilol based on porous starch matrices. The starch hydrogel was produced by incorporating water under heating and constant stirring, then the water was gradually replaced by ethanol from the system and finally the ethanol was removed by rotary evaporation. In this way, the pores of the starch were formed. The incorporation of the API was carried out by the method of loading by solvent evaporation and physical mixing, in proportions of 1:1, 2:1 and 3:1. The samples were submitted to Fourier transform infrared (FTIR), thermogravimetric (TGA), differential scanning calorimetry (DSC) and X-ray diffraction analysis. In the Thermogravimetric results for the system with solvent incorporation, there was a significant change in the behavior of the thermal transition referring to melting, so that, in the 3:1 ratio, the melting peak disappears. Infrared spectra corroborate the presence of the drug within the polymer matrix. Such statement can be confirmed by the characteristic band of the carvedilol drug at 1592 cm-1. XRD revealed that for the macerated system there was no adequate incorporation of the API to the matrix, but for the system with solvent incorporation, the Bragg peaks of the drug disappeared as the proportion of the porous matrix increased. Thus, it is possible to affirm that ASP is an excellent strategy for the amorphization of Carvedilol. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-09-16T15:10:33Z 2022-07-21 2022-09-16T15:10:33Z 2022-07-07 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/publishedVersion info:eu-repo/semantics/bachelorThesis info:eu-repo/semantics/dataset |
format |
bachelorThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
OLIVEIRA, Israel de França de. Amido poroso como dispositivo de amorfização de carvedilol. 2022. 44 f. Monografia (Bacharelado em Farmácia) - Instituto de Ciências Biológicas e da Saúde, Universidade Federal de Mato Grosso, Barra do Garças, 2022. http://bdm.ufmt.br/handle/1/2484 |
identifier_str_mv |
OLIVEIRA, Israel de França de. Amido poroso como dispositivo de amorfização de carvedilol. 2022. 44 f. Monografia (Bacharelado em Farmácia) - Instituto de Ciências Biológicas e da Saúde, Universidade Federal de Mato Grosso, Barra do Garças, 2022. |
url |
http://bdm.ufmt.br/handle/1/2484 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Universidade Federal de Mato Grosso Brasil Instituto de Ciências Biológicas e da Saúde (ICBS) – Araguaia UFMT CUA - Araguaia Farmácia - CUA |
publisher.none.fl_str_mv |
Universidade Federal de Mato Grosso Brasil Instituto de Ciências Biológicas e da Saúde (ICBS) – Araguaia UFMT CUA - Araguaia Farmácia - CUA |
dc.source.none.fl_str_mv |
reponame:Biblioteca Digital de Monografias da UFMT instname:Universidade Federal de Mato Grosso (UFMT) instacron:UFMT |
instname_str |
Universidade Federal de Mato Grosso (UFMT) |
instacron_str |
UFMT |
institution |
UFMT |
reponame_str |
Biblioteca Digital de Monografias da UFMT |
collection |
Biblioteca Digital de Monografias da UFMT |
repository.name.fl_str_mv |
Biblioteca Digital de Monografias da UFMT - Universidade Federal de Mato Grosso (UFMT) |
repository.mail.fl_str_mv |
bibliotecacentral@ufmt.br|| |
_version_ |
1813012963233103872 |